Method of treating periodontitis

FIELD: medicine.

SUBSTANCE: method involves application of a dressing on the periodontal tissues. Before the application of the dressing, the periodontal tissues are irrigated with Dentos solution for more than once. The dressing is prepared by adding zinc oxide power and zinc sulphate to Dentos and mixing them to pasty consistency. The solid dental tissues are coated with the polymer film from the vestibular and oral surfaces to a cutting edge. The periodontal tissues and the solid dental tissues coated with the polymer film are coated with the dressing.

EFFECT: method provides the anti-inflammatory, hardening, haemostatic capillary-reinforcing, immunomodulatory and adaptogenic effects; it enables maintaining the active substance concentration in the periodontal tissues, removing the dressing from the solid dental tissues, preventing colouring them and providing the Dentos exposure on the restoration components.

2 ex

 

The invention relates to medicine, namely to the dentist, and can be used for the treatment of inflammatory periodontal diseases.

A known number of indirect analogues to the claimed method.

There is a method of treating periodontal disease, which consists in the treatment of periodontal tissue drug immobilized sorbent for medical purposes on the basis of silica and etoniya [1].

The disadvantage of this method is that it does not have sufficient anti-inflammatory effect, does not provide the tanning effect is not optimal hemostatic, capillary, immunomodulatory and adaptogenic effects. The method does not allow prolonged to maintain the concentration of active substance in the periodontal tissues, does not possess the properties of compress.

There is a method of treating periodontal disease, which consists in the treatment of periodontal pockets 0.05% solution Miramistin, the imposition of the gingival dressing containing a mixture of 2% solution of calcium chloride, juice, Kalanchoe and nettle, glucosamine hydrochloride, dimethyl sulfoxide, and as a gel base used alloy oxides PEO-400 and PEO-4000 with glycerol [2].

The disadvantage of this method is that it does not have sufficient anti-inflammatory effect, does not provide Ecevit tanning effect does not have optimal hemostatic, capillary, immunomodulatory and adaptogenic effects. The method does not allow prolonged to maintain the concentration of active substance in the periodontal tissues, does not possess the properties of compress. Bandage traumatic and difficult subject to deletion.

There is a method of treating periodontal disease, comprising the adsorption of Epsilon-aminocaproic acid on the carbon sorbent and overlay applications of the composition of the drug in the gingival or periodontal pockets [3].

The disadvantage of this method is that it does not have sufficient anti-inflammatory effect, does not provide the tanning effect is not optimal hemostatic, capillary, immunomodulatory and adaptogenic effects. The method does not allow prolonged to maintain the concentration of active substances in the tissues of the periodontium, has no osmotic effect.

There is a method of treating periodontal disease, which consists in imposing on periodontal tissues of the medical bandage, prepared on the basis of oils of rosehip, sea buckthorn, Carolina, vitamins a and E with the addition of zinc oxide and zinc sulfate [4].

The disadvantage of this method is that it does not have sufficient anti-inflammatory effect, do not provide asego effect, does not have optimal hemostatic, capillary, immunomodulatory and adaptogenic effects. The method does not allow prolonged to maintain the concentration of active substances in the periodontal tissues, does not possess the properties of compress. Bandage traumatic and difficult subject to deletion.

This method is used for the prototype.

The aim of the invention are to provide an anti-inflammatory, tanning, hemostatic, capillary, immunomodulatory, adaptogenic effects, creating conditions for prolonged maintain the concentration of active substances in the tissues of the periodontium, the provision of medical bandage functions compress, atraumatic removal of the bandage with minimal effort.

This goal is achieved by the fact that before the imposition of medical bandages repeated irrigation of periodontal tissues with a solution "Dentos"; medical bandage is made by adding a powder of zinc oxide and zinc sulfate in the "Dentos and blend them to a paste-like consistency; hard tissue of teeth with vestibular and oral surfaces covered with plastic film to the cutting edge; on periodontal tissues and hard tissues of the teeth, which are coated with a polymer film, impose medical bandage.

The method of treatment of inflammatory periodontal diseases concludes the I in the following: under adequate anesthesia produce professional hygiene of the oral cavity in order to remove dental plaque; then produce multiple irrigation of periodontal tissues with a solution "Dentos". "Dentos" represents the extraction of the drug with anti-microbial and anti-inflammatory properties, contains the leaves of eucalyptus, calendula flowers, the bark of the oak, the herb Echinacea, essential oil of clove (eugenol) [5]. Made of medical dressing by adding a powder of zinc oxide and zinc sulfate in the "Dents" and blend them to a paste-like consistency to a glass spatula. Cover hard tissues of the teeth with vestibular and oral surfaces of the polymer film to the cutting edge. On periodontal tissues and hard tissues of the teeth, which are coated with a polymer film, impose medical bandage.

Using the new method and the results of its application are confirmed by the following clinical examples.

Clinical example 1. Patient M., 62. The diagnosis of chronic generalized periodontitis mild severity. It is noted spontaneous bleeding, gnetaceae from periodontal pockets. Under local anesthesia Sol. Ultracaini D. S. - 1.8 ml produced professional hygiene of the teeth on the lower jaw in order to remove dental plaque. Produced multiple irrigation of periodontal tissues on the lower jaw solution "Dentos". Manufactured treatment run is and by adding a powder of zinc oxide and zinc sulfate in the "Dents" and mixing them to a paste-like consistency to a glass spatula. Hard tissues of the teeth with vestibular and oral surfaces coated with a polymer film to the cutting edge. On periodontal tissues and hard tissues of the teeth, which are coated with a polymer film, impose medical bandage.

Recommendations are given. Scheduled follow-up visit. After 48 hours, the bandage is removed by traction at the edge of the polymer film covering the hard tissues of the teeth. Clinically, we observed no spontaneous bleeding. On the 3rd day of inflammation in periodontal pockets on the lower jaw cropped.

Clinical example 2. Patient R., aged 54. The diagnosis of chronic generalized periodontitis of moderate severity. It is noted spontaneous bleeding, limitiruyuschie gnetaceae from periodontal pockets. Under local anesthesia Sol. Ultracaini D. S. - 1.8 ml produced professional hygiene of the teeth on the upper jaw in order to remove dental plaque. Produced multiple irrigation of periodontal tissues in the upper jaw solution "Dentos". Manufactured medical bandage by adding a powder of zinc oxide and zinc sulfate in the "Dents" and mixing them to a paste-like consistency to a glass spatula. Hard tissues of the teeth with vestibular and oral surfaces coated with a polymer film to the cutting edge. On periodontal tissues and hard tissues of the teeth, which are coated with a polymer plait is coy, impose medical bandage.

Recommendations are given. Scheduled follow-up visit. After 48 hours, the bandage is removed by traction at the edge of the polymer film covering the hard tissues of the teeth. Clinically, we observed no spontaneous bleeding, reduction of sickness. On the 3rd day of inflammation in periodontal pockets on the lower jaw cropped.

The positive effect from the use of the proposed method is that in the treatment of inflammatory periodontal disease, the method provides anti-inflammatory, tanning, hemostatic capillary, immunomodulatory and adaptogenic effects. The method allows prolonged to maintain the concentration of active substances in the periodontal tissues, provides the function compress, allows atraumatic delete therapeutic bandage with minimal effort.

The proposed model can be used in dental offices dentistry and outpatient dental settings.

SOURCES of INFORMATION

1. RF patent for the invention №97115532, application No. 97115532/14 from 19.09.1997.

2. RF patent for the invention №2372949, application No. 2008128739/14, 14.07.2008.

3. RF patent for the invention №97100376, application No. 97100376/14, 14.01.1997.

4. Lukins L. M., Zhulev E. N., Chuprunova I. N. Periodontal diseases. - Nizhny Novgorod: Publishing house vangelovski state medical Academy, 2005, S. 95-96.

5. RF patent for the invention №2428171, application No. 2009143215/15 from 25.11.2009.

The method of treatment of periodontitis, including the imposition on periodontal tissues of the medical bandage, prepared on the basis of zinc oxide and zinc sulfate, characterized in that before the imposition of medical bandages repeated irrigation of periodontal tissues with a solution "Dentos"; medical bandage is made by adding a powder of zinc oxide and zinc sulfate in the "Dentos and blend them to a paste-like consistency; hard tissue of teeth with vestibular and oral surfaces covered with plastic film to the cutting edge; on periodontal tissues and hard tissues of the teeth, which are coated with a polymer film, impose medical bandage.



 

Same patents:

FIELD: medicine.

SUBSTANCE: Candida yeast-like fungi are measured. Lamypharen biogel is used to cover approximate dental surfaces along the quadrants (1.2) and (3.4) or (1.5-1.8, 1.4-2.4, 2.5-2.8), (3.5-3.8, 3.4-4.4, 4.5-4.8), into a gingival surface, inflamed surfaces of a gingival crest or into a gingival pockets. The exposure makes 20 to 30 minutes. After the gel is removed by means of Alod - 01-GRANAT diode laser, the gingival papillas or gingival pockets are treated. If the measured Candida yeast-like fungus content is 105-107 CFU/tampon or CFU/ml, the exposure length makes 2 minutes. If the measured value is 103-104 CFU/tampon or CFU/ml, the exposure length is 1 minute. What is used is a laser light at wave length 662nm with a radiation power of 0.4Wt, a power density of 14-18 J/cm2 in a continuous mode. That is followed by Lamypharen biogel applications on the gingival mucosa, into the gingival pockets covered with a protective dressing for 1-2 hours. The therapeutic course makes 3 procedures. Besides, Lamypharen biogel is administered orally once a day 30 minutes before a meal in an amount of 20 g for 14-30 days depending on a severity of the disease.

EFFECT: reducing the inflammation and pathogenic microflora, prolonging the remission of the disease by enhancing the inflow of biological substances into a chronic inflammatory periodontal tissues.

4 cl, 5 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to dentistry. A method for the conservative treatment of parodontium involves applying a treatment wrap prepared of zinc oxide and zinc sulphate; applying the treatment wrap is preceded by a multiple irrigation of parodontium tissues with butol solution; the treatment wrap is prepared by adding zinc oxide powder and zinc sulphate powder into butol solution and mixing them to pasty consistency; dental tissues from the vestibular and oral surfaces in the neck region are covered with a gauze drain of the diameter of 1-4mm saturated with butol solution; parodentium and dental tissues covered with the gauze drain saturated with butol solution is coated with the treatment wrap.

EFFECT: using the method enables achieving optimum diffusion of the therapeutic preparation in the parodontium tissue and its prolonged effect on parodontal tissues, with providing haemostatic effect and adequate anti-inflammatory action.

2 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to dentistry. A method of treating inflammatory diseases of parodentium involves administering a dosage form into gingival pockets and immersed fully underneath the gingival line; that is ensured by irrigating the gingival pockets with Dentos solution; an implant side for a medicinal thread is created by placing a retraction thread of a diameter exceeding that of the medicinal thread into the gingival pockets, or the implant side for the medicinal thread is created in the gingival pockets by scaling with an abrasion spoon or a scaler; saturated Dentos cotton medicinal thread or saturated Dentos medicinal resorbed carboxymethyl cellulose thread is introduced into the gingival pockets.

EFFECT: using the method provides the prolonged maintenance of the active substance concentration in the parodontium tissues with the active substance possessing antimicrobial and anti-inflammatory properties, and has a uniform effect along the whole perimeter of the gingival pocket that enables reducing the inflammatory process.

2 ex

FIELD: medicine.

SUBSTANCE: pharmaceutical composition contains recombinant interferon specified in a group: recombinant interferon alpha, recombinant interferon beta, recombinant interferon gamma, metronidazole, hypromellose, antiseptics and a consistency base in the following relation of ingredients, g per 1 ml of the mixture: recombinant interferon, IU 100-10,000,000; metronidazole 0.00001-0.5; hypromellose 0.00001-0.5; antiseptics 0.00001-0.5; consistency base - the rest. Besides, the pharmaceutical composition contains antibiotics specified in a group: baneocin, levomycin, tetracycline, amoxicilline in an amount of 0.00001-0.5 g. Besides, the pharmaceutical composition contains antiseptics specified in a group: boric acid, salicylic acid, hydrogen peroxide, chlorhexidine, ethanol, povidone iodine, silver nitrate, silver sulphadiazine in an amount of 0.00001-0.5 g. Besides, the pharmaceutical composition contains anesthesin or lidocaine as local anaesthetics in an amount of 0.00001-0.5 g. Besides, the pharmaceutical composition contains vitamin A or beta-carotene as food colorants in an amount of 0.00001-0.5 g. Besides, the pharmaceutical composition contains flavouring agents specified in a group of: tea tree oil, menthol oil, eucalyptus leaf oil in an amount of 0.00001-0.5 g. Besides, the pharmaceutical composition contains macrogol 400, or macrogol 1500, or macrogol 4000 as a consistency base.

EFFECT: more effective treatment.

7 cl, 11 ex

FIELD: medicine.

SUBSTANCE: invention represents a therapeutic agent for oral cleaning in individuals suffering xerostomia, possessing antiseptic action and presented as spray, gel and mouthwash, containing a drug, differing by the fact that the drug contains hypromellose, boric acid and a flavour specified in a group: tea tree oil, menthol oil, eucalyptus oil and a consistency base in the following relations, g per 1ml of mixture: hypromellose 0.00001-0.5; boric acid 0.00001-0.5; flavour 0.00001-0.5; consistency base - the rest.

EFFECT: improving the properties of the agent.

2 cl, 6 ex

FIELD: medicine.

SUBSTANCE: method involves preliminary assessment of the reversible abnormal changes of enamel accompanying early cariosity. That is ensured by diagnostic tests of solid dental tissues conducted by using light-induced fluorescence and electrometric measurement techniques followed by therapy involving daily applications of the Radogel-GABA preparation. If observing visually detected changes with a current intensity of 0.21-1.99 mcA in the lesion and the presence of fluorescence, the preclinical changes of enamel are diagnosed requiring 5 therapeutic procedures with the above preparation. Visualised tarnishing of enamel accompanied by a current intensity of 2.00-3.99 mcA in the lesion and the presence of fluorescence, an early carious change of enamel at the stage of a dead spot is diagnosed, and 7 therapeutic procedures are conducted. If visualising a white spot of enamel accompanied by a current intensity of 4.00-5.99 mcA in the lesion and the presence of fluorescence, an early carious change of enamel at the stage of a white spot is diagnosed, and 10 therapeutic procedures are conducted. If visualising a white spot of enamel accompanied by a current intensity of 6.00-7.99 mcA in the lesion and the presence of fluorescence, an early carious change of enamel at the stage of an intense white spot is diagnosed, and 15 therapeutic procedures with the Radogel-GABA preparation are required.

EFFECT: method provides the high-effective therapeutic exposure on caries by the timely recovery of the protein dental matrix with simplicity and ease of use at massive dental visits.

2 tbl

FIELD: medicine.

SUBSTANCE: formulation of initial ingredients of the presented tooth paste for treating and preventing dento-facial inflammatory diseases involves a tissue regeneration stimulator specified in hyaluronic acid or sucralfate, or ε-acetylaminocapronic acid sodium salt, the enzymes lysozyme, papaine and hyaluronidase, as well as an abrasive ingredient, a moistening agent, hydrocolloid, a surfactant, sodium fluoride, tetrapotassium pyrophosphate, a preserving agent, a flavouring agent and water in certain amounts.

EFFECT: effective oral cleaning and removal of plaque, reduced bleeding gum and oral inflammations, faster dento-facial regeneration in the inflammations.

4 cl, 9 tbl, 3 ex

FIELD: medicine.

SUBSTANCE: formulation for the prevention of dental and parodontal diseases comprises inula rhizome and root tea, sodium benzoate, sorbitol, a flavour and water in the following proportions, wt %: inula rhizome and root tea 0.3-20.0; sodium benzoate 0.1-0.3; sorbitol 14.0-35.0; flavour 0.3-2.0; water - the rest. The formulation can be used for a wide circle of patients, including in paediatric dentistry, for people suffering chronic cardiovascular diseases, and for drivers.

EFFECT: pronounced preventive and therapeutic effect, particularly anti-caries and anti-inflammatory one.

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutics and represents a method of treating periodontitis by instillations of the Cholisal gel into the gingival pockets and gingival applications 2-3 times a day for 20 days; the method differs by prescribing the Calcium-vit D3C preparation 1 capsule twice a day for one month, with the therapeutic course repeated 6 months later.

EFFECT: invention provides the higher effectiveness of the method of treating periodontitis by achieving the osteotropic and immunotropic action alongside with the local bactericidal and anti-inflammatory effect.

3 ex, 3 tbl

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to dentistry, and can be used for the preventing and treating infectious processes accompanying dental surgeries. That is ensured by intraoperative administration of a therapeutic antibacterial preparation of penicillin and an antibacterial preparation of the third-generation cephalosporin. The above preparation is administered daily for 3-5 postoperative days. The above preparation is administered intra- and post-operatively once a day intravenously drop by drop for 15-35 minutes in a dose of 30-55% of the recommended daily dose.

EFFECT: invention enables reducing a possibility of antibiotic dosage with complete withdrawal of repeated intra- and post-operative one-day administration of the antibiotics, with avoiding the developing early and late postoperative infectious-inflammatory complications.

3 cl, 5 ex

FIELD: medicine.

SUBSTANCE: treating locally advanced oropharyngeal cancer is ensured by a radiation therapy in the mode of dynamic dose fractionation. The radiation therapy is started by supplying a fraction dose of 2.4 Gy. After 2 days of treatment gap, the patient is exposed to total fractions at a fraction dose of 3.6Gy for three days. Each session is precede by placing high-structure hydrogel matrix of sodium alginate under a patient's tongue with metronidazole 150mg and bilberry 20-35mg pre-introduced into the matrix, for 4-5 hours twice every 1-2 hours. The two following sessions of the exposure at a fraction dose of 2.4 Gy are preceded by placing the matrix once under the tongue for 4-5 hours. After 2 days of treatment gap, the following 5 sessions of the radiation therapy are performed at a fraction dose of 2.4 Gy to a cumulative dose of 30Gy. Colegel-DNA-Ch high-structure disk is preliminary placed under the tongue for 4-5 hours.

EFFECT: method enables avoiding the compulsory gaps of the radiation therapy by reducing a rate of severe local radiation reactions, and provides the target delivery and accurate dosage of metronidazole administered into the patient's body leading to the partial death of well-oxygenated cells and re-oxygenation of hypoxic tumour cells.

2 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine and cosmetology and can be used for the effective transdermal delivery of the wide range of active substances (AS). What is declared is a method for the transdermal delivery of the active substances as a part of PEG-12 dimethicone niosomes characterised by the fact that the AS are included into the niosomes in the concentration of 10% by homogenising gel containing 10% niosomes in the homogeniser APV.

EFFECT: invention provides the higher transdermal effect of the interstitial delivery of the AS as a part of the niosomes.

3 tbl, 2 dwg

FIELD: chemistry.

SUBSTANCE: method of obtaining sanguinarine and chelerythrine sulphates includes extraction of milled overground part of macleaya microcarpa and/or macleaya cordata with water aliphatic alcohol, removal of water aliphatic alcohol in vacuum, alkalinisation of water distillation residue with hydrophobic solvent, processing organic phase with sulphuric acid, filtration, washing and drying of target product, with extraction of milled raw material being carried out with water aliphatic alcohol in presence of methanesulphoacid, and solution of alkaloid bases in hydrophobic organic solvent is additionally filtered through layer of hydrophobic solvent, and target product is subjected to boiling in acetone.

EFFECT: method makes it possible to increase quality of finished product, simplify technology of production of sanguinarine and chelerythrine sulphates, and reduce the process duration.

8 cl, 14 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: present invention refers to the pharmaceutical industry, namely to a composition possessing the analgesic and anti-inflammatory action (versions). A topical composition possessing the analgesic and anti-inflammatory action and containing chondroitin sulphate, phenyl trimethicone, stabilene 30, cetyl alcohol, cetyl palmitate, Carbopol, a wetting agent, triethanolamine, glucosamine hydrochloride, liposomes, beta-cyclodextrin, bitter orange flower oil, Lavandula angustifoiia oil, escin, betulin, hyaluronidase, ginger extract, harpagophytum extract, euxyl k727, demineralised water in certain proportions. The topical composition possessing the analgesic and anti-inflammatory action and containing chondroitin sulphate, phenyl trimethicone, stabilene 30, cetyl alcohol, cetyl palmitate, Carbopol, a wetting agent, triethanolamine, glucosamine hydrochloride, liposomes, beta-cyclodextrin, bitter orange flower oil, Lavandula angustifoiia oil, escin, betulin, hyaluronidase, ginger extract, harpagophytum extract, euxyl k727, demineralised water in certain proportions.

EFFECT: compositions possess the pronounced analgesic and anti-inflammatory effect; they are stable.

2 cl, 1 tbl, 6 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to therapy, and concerns preventing and treating atherosclerosis. That is ensured by prescribing tablets or capsules with their active ingredients representing black elder blossom, marigold blossom and violet herb in certain proportions. Two tablets or two capsules are administered two times a day every 12 hours within the unlimited therapeutic course.

EFFECT: method provides the effective prevention and treatment of atherosclerosis, including reducing a thickness of carotid artery intima-medial thickness by suppressing the expression of anti-inflammatory cytokines and reducing blood serum atherogenicity.

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to the pharmaceutical industry, namely to a cholinergic agent. A mixture of bornyl acetate and camphene taken in a certain ratio possessing the cholinergic action.

EFFECT: above mixture possesses the pronounced cholinergic action.

3 tbl, 2 ex

FIELD: medicine.

SUBSTANCE: method involves the exposure of biologically active points (BAPs), the intake of herbal teas, the conflict management and the compliance with sleep mode. The BAPs exposure is conducted by finger pressing and twisting. The exposure takes the first 10 days of the therapeutic course. The exposure length is 3-5 minutes and involves the finger pressing and clockwise twisting in the moderating rhythm. On the odd-numbered day, the exposure covers a group of points found on the meridians, including a posterior median one - one point, an anterior median one - two points, a spleen - a pancreas - one point, a stomach - one point, lungs - one point, a liver - one point, kidneys - one point, and an urinary bladder - one point. On the even-numbered day, the exposure covers a group of points found on the meridians, including a posterior median one - one point, an anterior median one - two points, a spleen - a pancreas - one point, lungs - one point, a liver - one point, kidneys - one point, and an urinary bladder - two points. The whole therapeutic course is of the length of 3.5-4.0 months; in the first two months, herbal tea of milfoil is taken, while in the second two months - herbal teas of centaury and St. John's wort. The therapeutic course is accompanied by complying with the general and water schedules.

EFFECT: method provides the higher clinical effectiveness ensured by avoiding the psychological rejection of the conducted treatment and creating the health memory in the children.

5 cl, 3 ex

FIELD: medicine.

SUBSTANCE: Candida yeast-like fungi are measured. Lamypharen biogel is used to cover approximate dental surfaces along the quadrants (1.2) and (3.4) or (1.5-1.8, 1.4-2.4, 2.5-2.8), (3.5-3.8, 3.4-4.4, 4.5-4.8), into a gingival surface, inflamed surfaces of a gingival crest or into a gingival pockets. The exposure makes 20 to 30 minutes. After the gel is removed by means of Alod - 01-GRANAT diode laser, the gingival papillas or gingival pockets are treated. If the measured Candida yeast-like fungus content is 105-107 CFU/tampon or CFU/ml, the exposure length makes 2 minutes. If the measured value is 103-104 CFU/tampon or CFU/ml, the exposure length is 1 minute. What is used is a laser light at wave length 662nm with a radiation power of 0.4Wt, a power density of 14-18 J/cm2 in a continuous mode. That is followed by Lamypharen biogel applications on the gingival mucosa, into the gingival pockets covered with a protective dressing for 1-2 hours. The therapeutic course makes 3 procedures. Besides, Lamypharen biogel is administered orally once a day 30 minutes before a meal in an amount of 20 g for 14-30 days depending on a severity of the disease.

EFFECT: reducing the inflammation and pathogenic microflora, prolonging the remission of the disease by enhancing the inflow of biological substances into a chronic inflammatory periodontal tissues.

4 cl, 5 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to the chemical-pharmaceutical industry and represents a composition of oral care agents involving silicone dioxide particles in an amount of 5 to 50 wt % of the composition weight, wherein the silicone dioxide particles have an oil absorption value to 100 cm3/100 g, a sphericity coefficient (S80) of more than 0.9 and the Brass-Einlener abrasive wear of less than 8.0 mg loss/100,000 revolutions, wherein at least 80% particles of silicone dioxide are shaped from rounded to round.

EFFECT: improving the composition.

13 cl, 6 ex, 13 dwg, 10 tbl

FIELD: medicine.

SUBSTANCE: immunocorrective agent for the therapy of atherosclerotic diseases containing hawthorn blossom, common St. John's wort herb, as well as calcium stearate and silicone oxide taken in certain proportions.

EFFECT: agent is effective for the therapy of atherosclerotic diseases.

8 ex

Wound bandage // 2538808

FIELD: medicine.

SUBSTANCE: invention relates to medical equipment, namely to wound bandages. Wound bandage for wound treatment from medium to high exudation contains carrying layer and absorbing pillow, with absorbing pillow including first absorbing layer, which contains first absorbing material, and different from first layer second absorbing layer, which contains different from first material second absorbing material, with first layer being held at a distance from second layer by at least one third layer, and third layer contains at least one antimicrobial preparation, characterised by the fact that second absorbing material contains fibres, which possess super-high absorption ability, and absorbing pillow additionally contains contacting with wound layer, which is in direct contact with first layer, and contacting with wound layer represents polymer net or perforated polymer film, and antimicrobial means represents elementary silver, silver oxide, silver complex, or silver salt, or their mixtures, and fibres which have super-high absorption ability are obtained from salts of polyacrylic acids or polyacrylates.

EFFECT: application of invention makes it possible to reduce risk of sticking to wound and simultaneously counteract maceration, without loading wound to be treated with excessive biologically active substances.

8 cl, 3 dwg

Up!